MedPath

太仓神州生物制药有限公司

Ownership
-
Established
2019-09-26
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

8

NMPA:8

Drug Approvals

Sulfasalazine

Product Name
柳氮磺吡啶
Approval Number
国药准字H32021584
Approval Date
Jul 30, 2020
NMPA

Tinidazole Capsules

Product Name
乐净
Approval Number
国药准字H10970035
Approval Date
Jul 21, 2020
NMPA

Tinidazole Capsules

Product Name
乐净
Approval Number
国药准字H10970036
Approval Date
Jul 21, 2020
NMPA

Paracetamol,Pseudoephedrine Hydrochloride and Chlorphenamine Maleate Granules

Product Name
服克
Approval Number
国药准字H32025363
Approval Date
Jul 14, 2020
NMPA

Dimenhydrinate Tablets

Product Name
茶苯海明片
Approval Number
国药准字H19983186
Approval Date
Jul 14, 2020
NMPA

Tinidazole Vaginal Effervescent Tablets

Product Name
乐净怡
Approval Number
国药准字H20000147
Approval Date
Sep 3, 2015
NMPA

Lomefloxacin Hydrochloride Tablets

Product Name
维普
Approval Number
国药准字H20010124
Approval Date
Jul 29, 2015
NMPA

Glipizide Sustained Release Capsules

Product Name
麦林格
Approval Number
国药准字H20000052
Approval Date
Jul 14, 2015
NMPA

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.